Clinical Trials Browser

Phase 3 × Neurotoxicity Syndromes × Duloxetine Hydrochloride × Clear all

NCT00489411 2017-04-26

Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Phase 3 Completed

231 enrolled 14 charts

Pain, Peripheral Nervous System Diseases, Neurotoxicity Syndromes